Literature DB >> 6128021

Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.

R K Ferguson, P H Vlasses, J R Koplin, G I Holmes, P Huber, J Demetriades, W B Abrams.   

Abstract

1 We investigated the relationships among dose, plasma concentration and beta-adrenoceptor blockade after single and repeated doses (0.5-20 mg) of timolol and placebo in six normal men. 2 Maximal suppression of exercise-induced tachycardia (bicycle ergometry) was dose-dependent and greater at 2 than at 6 h after dosing; activity up to 12 h was evident on the last dosing day. 3 Attenuation of exercise-induced tachycardia was strongly correlated with the timolol dosage over the 0.5 to 5-10 mg range. 4 A plasma timolol concentration of 27 ng/ml was associated with maximal suppression of exercise-induced tachycardia. 5 Suppression of exercise-induced tachycardia and areas under the plasma concentration-time curves did not differ significantly on the first and last dosing days.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128021      PMCID: PMC1427501          DOI: 10.1111/j.1365-2125.1982.tb04963.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Physiological disposition and metabolism of timolol in man and laboratory animals.

Authors:  D J Tocco; A E Duncan; F A Delauna; H B Hucker; V F Gruber; W J Vandenheuvel
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

2.  Duration of cardiac effects of timolol and propranolol.

Authors:  M R Achong; K M Piafsky; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man.

Authors:  M Ulrych; J Franciosa; J Conway
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

5.  Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

6.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

7.  Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.

Authors:  A Scriabine; M L Torchiana; J M Stavorski; C T Ludden; D H Minsker; C A Stone
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-09

Review 8.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Electron-capture GLC determination of timolol in human plasma and urine.

Authors:  D J Tocco; F A deLuna; A E Duncan
Journal:  J Pharm Sci       Date:  1975-11       Impact factor: 3.534

10.  Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.

Authors:  T Ishizaki; K Tawara; Y Oyama; H Nakaya
Journal:  J Clin Pharmacol       Date:  1978 Nov-Dec       Impact factor: 3.126

View more
  6 in total

1.  Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).

Authors:  M N Martinez; A J Jackson
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

Review 2.  Clinical significance of genetic influences on cardiovascular drug metabolism.

Authors:  L Arcavi; N L Benowitz
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

3.  Wild-type levels of abscisic Acid are not required for heat shock protein accumulation in tomato.

Authors:  E A Bray
Journal:  Plant Physiol       Date:  1991-10       Impact factor: 8.340

4.  Estimation and Analysis of Cucumber (Cucumis sativus L.) Leaf Cellular Heat Sensitivity.

Authors:  C. R. Caldwell
Journal:  Plant Physiol       Date:  1993-03       Impact factor: 8.340

5.  Modification of the Cellular Heat Sensitivity of Cucumber by Growth under Supplemental Ultraviolet-B Radiation.

Authors:  C. R. Caldwell
Journal:  Plant Physiol       Date:  1994-02       Impact factor: 8.340

6.  Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics.

Authors:  R V Lewis; M S Lennard; P R Jackson; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.